Causes of Death Among Waldenström Macroglobulinemia Patients: A Population-Based Study
Clinical Lymphoma Myeloma and Leukemia · 2026-04 · 26 (4) · e442-e451.e4
DOI: 10.1016/j.clml.2025.09.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-04. Verfasst von Dan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dpartment of Hematology, Shaoxing People's Hospital. Shaoxing City, Zhejiang Province, China. Hauptthemen laut MEDLINE: Cause of Death, Waldenstrom Macroglobulinemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents.
Abstract (Originalsprache)
BACKGROUND: Waldenström macroglobulinemia (WM) is a rare, indolent lymphoma, and death from non-WM causes has become increasingly important in treatment decisions. This study explored the causes of death in WM patients. METHODS: The data from 8894 patients diagnosed with WM in the Surveillance, Epidemiology, and End Results (SEER) database from 1980 to 2016 were included. Standardized mortality ratios (SMRs) were used to assess the relative risk of death compared with that of the general US population. RESULTS: Considering other competing events, the 5-year cumulative incidences of death from the index cancer, SMNs and noncancer causes were 8.6% (SD: 1.00e-05), 10.02% (SD: 1.17e-05) and 16.14% (SD: 1.79e-05), respectively, among WM patients. WM patients had the highest SMR for index cancer-related death, at 121.84 (95% CI, 103.8-142.11) in the first year after diagnosis, which declined thereafter. Among nonindex cancer-related deaths, hematological malignancy-related deaths were notably increased, whereas solid neoplasm deaths were elevated only 10 years after diagnosis (SMR, 1.43; 95% CI, 1.06-1.9). Among noncancer causes of death, infection, particularly among patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dpartment of Hematology, Shaoxing People's Hospital. Shaoxing City, Zhejiang Province, China.
- Dpartment of Hematology, Shaoxing People's Hospital. Shaoxing City, Zhejiang Province, China. Electronic address: fengweiying1997@126.com.
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents
Zitieren
APA
Li, D., Han, J., Jin, J., Hong, L., Hong, P., & Feng, W. (2026). Causes of Death Among Waldenström Macroglobulinemia Patients: A Population-Based Study. Clinical Lymphoma Myeloma and Leukemia, 26(4), e442-e451.e4. https://doi.org/10.1016/j.clml.2025.09.005
Vancouver
Li D, Han J, Jin J, Hong L, Hong P, Feng W. Causes of Death Among Waldenström Macroglobulinemia Patients: A Population-Based Study. Clinical Lymphoma Myeloma and Leukemia. 2026;26(4):e442-e451.e4. doi:10.1016/j.clml.2025.09.005
BibTeX
@article{Li2026,
author = {Li, Dan and Han, Jiongping and Jin, Jing and Hong, Li and Hong, Pan and Feng, Weiying},
title = {Causes of Death Among Waldenström Macroglobulinemia Patients: A Population-Based Study},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {4},
pages = {e442--e451.e4},
doi = {10.1016/j.clml.2025.09.005}
}
EUVIMED